HDAC9 and Alzheimer disease: MMP2 also plays a crucial role in epigenetic modifications related to AD by facilitating myogenic gene activation and Aβ degradation [25], as demonstrated by the effects of novel HDAC inhibitors that target MMP2 activity [32].